Page last updated: 2024-09-03

aschantin and epidermal growth factor

aschantin has been researched along with epidermal growth factor in 1 studies

Compound Research Comparison

Studies
(aschantin)
Trials
(aschantin)
Recent Studies (post-2010)
(aschantin)
Studies
(epidermal growth factor)
Trials
(epidermal growth factor)
Recent Studies (post-2010) (epidermal growth factor)
50424,1552174,699

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, YY; Choi, KI; Dong, Z; Jang, JH; Lee, CJ; Lee, HS; Lee, JY; Lee, MH; Li, Y; Oh, SR; Ryu, HW; Surh, YJ1

Other Studies

1 other study(ies) available for aschantin and epidermal growth factor

ArticleYear
Aschantin targeting on the kinase domain of mammalian target of rapamycin suppresses epidermal growth factor-induced neoplastic cell transformation.
    Carcinogenesis, 2015, Volume: 36, Issue:10

    Topics: Animals; Benzodioxoles; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lignans; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Multiprotein Complexes; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2015